Bioorthogonally activated reactive species for target identification
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Massachusetts Life Sciences Center
- National Institutes of Health (DP2 ES030448)
- National Institutes of Health (R01 CA233800)
- National Institutes of Health (R21 CA247671)
- Mark Foundation For Cancer Research
This publication has 30 references indexed in Scilit:
- Leveraging Gas-Phase Fragmentation Pathways for Improved Identification and Selective Detection of Targets Modified by Covalent ProbesAnalytical Chemistry, 2016
- Version 4.0 of PaxDb: Protein abundance data, integrated across model organisms, tissues, and cell‐linesProteomics, 2015
- Target identification and mechanism of action in chemical biology and drug discoveryNature Chemical Biology, 2013
- From noncovalent to covalent bonds: a paradigm shift in target protein identificationMolecular BioSystems, 2012
- Chemoproteomic approaches to drug target identification and drug profilingBioorganic & Medicinal Chemistry, 2012
- Recent advances and method development for drug target identificationTrends in Pharmacological Sciences, 2010
- Finding the target after screening the phenotypeDrug Discovery Today, 2005
- Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N.1996
- Photoaffinity Labeling of Peptide Hormone Binding SitesJournal of Biological Chemistry, 1974
- Aryldiazirines. Potential reagents for photolabeling of biological receptor sitesJournal of the American Chemical Society, 1973